Atwood & Palmer’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1K Hold
75
﹤0.01% 370
2025
Q1
$12.8K Hold
75
﹤0.01% 315
2024
Q4
$12.5K Hold
75
﹤0.01% 325
2024
Q3
$12.9K Hold
75
﹤0.01% 319
2024
Q2
$11.6K Hold
75
﹤0.01% 331
2024
Q1
$11.5K Hold
75
﹤0.01% 302
2023
Q4
$11.9K Hold
75
﹤0.01% 308
2023
Q3
$11K Hold
75
﹤0.01% 301
2023
Q2
$11.5K Hold
75
﹤0.01% 309
2023
Q1
$11.6K Hold
75
﹤0.01% 293
2022
Q4
$11.6K Hold
75
﹤0.01% 313
2022
Q3
$10K Hold
75
﹤0.01% 304
2022
Q2
$10K Hold
75
﹤0.01% 323
2022
Q1
$11K Sell
75
-80
-52% -$11.7K ﹤0.01% 358
2021
Q4
$25K Sell
155
-65
-30% -$10.5K ﹤0.01% 295
2021
Q3
$37K Hold
220
﹤0.01% 243
2021
Q2
$38K Sell
220
-605
-73% -$105K ﹤0.01% 239
2021
Q1
$132K Sell
825
-9,530
-92% -$1.52M 0.01% 164
2020
Q4
$1.74M Sell
10,355
-335
-3% -$56.3K 0.19% 66
2020
Q3
$1.68M Buy
10,690
+10,515
+6,009% +$1.65M 0.21% 60
2020
Q2
$29K Hold
175
﹤0.01% 206
2020
Q1
$23K Hold
175
﹤0.01% 213
2019
Q4
$26K Sell
175
-125
-42% -$18.6K ﹤0.01% 210
2019
Q3
$37K Sell
300
-14,050
-98% -$1.73M 0.01% 203
2019
Q2
$2.02M Buy
14,350
+215
+2% +$30.3K 0.27% 52
2019
Q1
$2.13M Buy
14,135
+285
+2% +$43K 0.3% 49
2018
Q4
$1.72M Buy
13,850
+105
+0.8% +$13K 0.27% 53
2018
Q3
$2.18M Buy
+13,745
New +$2.18M 0.28% 50
2017
Q1
Sell
-18
Closed -$2K 306
2016
Q4
$2K Hold
18
﹤0.01% 318
2016
Q3
$2K Hold
18
﹤0.01% 310
2016
Q2
$2K Hold
18
﹤0.01% 292
2016
Q1
$2K Sell
18
-13,224
-100% -$1.47M ﹤0.01% 299
2015
Q4
$1.5M Buy
13,242
+807
+6% +$91.2K 0.28% 57
2015
Q3
$1.26M Buy
12,435
+395
+3% +$40K 0.25% 60
2015
Q2
$1.49M Sell
12,040
-35
-0.3% -$4.34K 0.27% 60
2015
Q1
$1.43M Sell
12,075
-780
-6% -$92.2K 0.25% 61
2014
Q4
$1.31M Buy
12,855
+1,680
+15% +$171K 0.24% 56
2014
Q3
$1.03M Buy
11,175
+65
+0.6% +$5.97K 0.19% 65
2014
Q2
$915K Buy
11,110
+3,080
+38% +$254K 0.24% 59
2014
Q1
$616K Buy
8,030
+245
+3% +$18.8K 0.14% 65
2013
Q4
$539K Buy
7,785
+5
+0.1% +$346 0.13% 72
2013
Q3
$504K Buy
7,780
+4,245
+120% +$275K 0.14% 70
2013
Q2
$206K Buy
+3,535
New +$206K 0.06% 97